Heath Lukatch, Director at Vaxcyte, Inc. (PCVX), sold 25,709 shares at $62.85 ($1.6M) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.85 | 1,101 | $69K | 4.2% |
| 2 | $62.85 | 1,101 | $69K | 4.2% |
| 3 | $63.55 | 7,444 | $473K | 28.9% |
| 4 | $63.55 | 7,444 | $473K | 28.9% |
| 5 | $64.28 | 4,164 | $268K | 16.3% |
| 6 | $64.28 | 4,164 |
| $268K |
| 16.3% |
| 7 | $65.19 | 291 | $19K | 1.2% |
| Total | $63.75 avg | 25,709 | $1.6M | 100% |
| Filing → |
| PCVX | SELL | 2023-01-12 | $15K | — | Filing → |
| PCVX | SELL | 2022-12-14 | $15K | — | Filing → |
| PCVX | SELL | 2022-11-15 | $200K | — | Filing → |